Skip to main content
. 1999 May;43(5):1170–1176. doi: 10.1128/aac.43.5.1170

TABLE 1.

Bacterial strains

Species and strain β-lactamase(s) produceda Description Sourcec or reference
K. pneumoniae
 CL 5188 TEM-10, SHV-1 Clinical isolate J. P. Quinn
 CL 5189 TEM-10, SHV-1 Clinical isolate J. P. Quinn
 CL 5128 TEM-5 Clinical isolate G. Jacoby
 CL 5196 TEM-10 Clinical isolate J. P. Quinn
 CL 5203 Unchar. ESBLb Clinical isolate C. Urban
 CL 5212 Unchar. ESBLb Clinical isolate C. Urban
E. coli
 CL 5121 SHV-1 Clinical isolate G. Jacoby
 CL 5190 TEM-10 Clinical isolate J. P. Quinn
 CL 5115 TEM-1 Clinical isolate G. Jacoby
 CL 5120 TEM-7 Clinical isolate G. Jacoby
 CL 5197 TEM-12 Clinical isolate J. P. Quinn
 MB5503 Bush group 1 Strain LS619 (envA+) 28
 DH5α Bush group 1 F φ80 ΔlacZ ΔM15 Δ(lacZYA-argF)U169 deoR recA1 endA1 hsdR17(rK mK+) supE44 λ thi-1 gyrA96 relA1 BRL
 LS641 Bush group 1 Resistant to fusidic acid K. Young and L. L. Silver, MRL
 MB4903 Bush group 1 Strain LS584 28
 KN126 (MB4303) Bush group 1 14
a

No additional β-lactamases are known to be produced. 

b

Enzymes have not been characterized; however, since these strains and those included in studies by Urban et al. (26) have a common origin, it is inferred that they carry the TEM-26 enzyme (26a). Unchar., uncharacterized. 

c

J. P. Quinn is at Columbus Hospital, Chicago, Ill., G. Jacoby is at Massachusetts General Hospital, Boston, Mass., and C. Urban is at New York Hospital Medical Center, New York, N.Y.